A

Akari Therapeutics plc

D
AKTX
USD
-0.1
(-4.065%)
Market Closed
1.00000
حجم التداول
-3.4
الربح لكل سهم
-
العائد الربحي
-0.789837
P/E
28,661,293.76
حجم السوق
اليوم
-4.0650%
1 اسبوع
-1.667%
1 شهر
-5.600%
6 اشهر
63.889%
12 اشهر
-26.935%
بداية السنة
-21.333%
كل الوقت
0%
avatar
sara abdelazim
عدد النقاط
112
عدد التوصيات
2

Title:
Akari Therapeutics plc

Sector:
Healthcare
Industry:
Biotechnology
Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing therapies for autoimmune and inflammatory diseases involving the complement component 5 (C5) and leukotriene B4 (LTB4) pathways. The company's pipelines include HSCT-TMA and Geographic Atrophy (GA).
هل تحتاج مساعدة او لديك استفسار؟